베인은 홈페이지 기능 및 성능 개선을 위해 쿠키를 사용합니다. 이와 관련된 더 많은 정보는 개인정보 메뉴에서 확인하실 수 있습니다. 이 웹사이트를 계속 사용하시면 쿠키 사용에 동의하신 것으로 간주됩니다. 

스냅차트

Doctors in India See a Rise in Digital Interactions with Pharma and Medtech Companies

Covid-19 has accelerated physicians’ use of digital channels to consume scientific content.

스냅차트

Doctors in India See a Rise in Digital Interactions with Pharma and Medtech Companies
en

During Covid-19, the percentage of physicians in India accessing scientific content published by pharma and medtech companies has grown by more than 40%, according to research by India-based data foundation THB. Looking forward, about 85% of doctors in India believe that digital exchanges with pharma and medtech firms will be as important as (if not more important than) face-to-face interactions with sales reps, medical liaisons and marketing staff. Nearly 50% say that, in the future, they will engage with healthcare companies more via digital channels than face-to-face. As marketing to doctors in India takes a digital leap forward, successful pharma and medtech companies are starting to differentiate themselves by incorporating digital options into their commercial operating models and ensuring that they have the appropriate channels, content and formats.

This research was conducted by THB, a technology, healthcare and big data analytics company based in India.  THB's platform provides digital scientific education and helps patients connect digitally with clinicians. During the last 12 months, the platform has enabled more than 4 million patient consultations with more than 250,000 doctors. THB's platform offers physicians proprietary clinical insights, evidence and research from real-world data across more than 25 therapy areas.

태그

베인에 궁금하신 점이 있으신가요?

베인은 글로벌 리더들이 중요한 이슈를 해결하고 기회를 놓치지 않도록 지원합니다. 고객사와 협력하여 지속되는 변화와 성과를 창출합니다.